 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval/ b! g% i) t# k2 F* g9 Y
9 o3 k& r% c% q9 _9 D. G
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
* F9 r( ?) `/ S7 i9 L2 T 5 t! X# x! Q" u% |% i
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007$ y3 ^5 q. L5 ]/ u3 ~
0 \' a2 O! U. Z; Z$ s+ r 0 l2 m# `8 |- I6 k
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
* m7 d8 ]% O3 ]' p) G
( W9 ]6 L6 w* B0 nThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
8 _2 @2 H1 L/ e, E, A; k# K+ ~9 l3 C8 y; O$ n, [
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.. u! s/ B" M* w0 K
" x5 U3 }5 q& u
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.) c2 e/ Y$ l8 @% A0 Q
! |$ H; @, Z* e% V! u) LIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
$ G+ I Z) O6 v' A
. [5 w! o! \; I3 r. W) Q1 S1 R' A"As a scientist, it's one of the highlights of my CAREER," Shan said.
; g- a; e6 _, W. O. M$ ~# O: _1 v$ Z: o1 m- c8 r T0 |
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention.") q6 O4 C% W& l3 W
) _% c& l7 J! H# v# u1 Z
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
+ n% X V$ q" C$ g3 [8 r4 B6 A
* m9 |$ H. d3 HGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
0 l- k9 m* P, d- h4 @- l) P* }5 ~; A+ { C! |: s
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
$ k" u( E( ]# H/ O- H6 w+ N! u5 ^1 o2 C4 r
- L6 g( o* ?! p' u, r, d
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|